Treatment of Polycystic Ovarian Syndrome through Individualised Homoeopathic Medicine: Two Case Reports

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common metabolic and reproductive disorders among women of reproductive age. Women suffering from PCOS present with menstrual dysfunction and androgen excess. Two patients aged 16 and 19 years suffering from PCOS were treated successfully with individualised homoeopathic medicine. These two cases of PCOS were treated with marked improvement within 1.5 years by individualised homoeopathic medicine with change in potency and repetition as per requirement. Modified Naranjo Criteria for Homeopathy (MONARCH) was used as a tool for attributing a causal relationship between the homoeopathic intervention and outcome. Visual analogue scale was used as a tool for assessing pain during menses (dysmenorrhoea). The improvement is evident from the regularity of the menstrual cycle, along with the resolution of cysts in ovaries as evidenced by ultrasonography reports which indicate a positive response of homoeopathy in relieving the symptoms as well as pathology associated with PCOS.

Keywords

polycystic ovarian syndrome - homoeopathy - hirsutism - polycystic ovaries - hyperandrogenism - infertility

• References

• 1 El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly Cystic ovarian syndrome: an updated overview. Front Physiol 2016; 7: 124 2022
• 2 Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P&T 2013; 38 (06) 336-355
• 3 Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370 (9588) 685-697
• 4 Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4 (02) 45-51
• 5 Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med 2018; 40 (03) 239-246
• 6 Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010; 93 (07) 2421-2423
• 7 Vidya Bharathi R, Swetha S, Neerajaa J. et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J 2017; 22 (04) 313-316
• 8 Hahnemann S. Organon of Medicine. 6th ed.. New Delhi, India: B Jain Publishers; 2021
• 9 Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 2015; 7: 745-763
• 10 Rashid R, Mir SA, Kareem O. et al. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol 2022; 61 (01) 40-50
• 11 Moghetti P, Castello R, Negri C. et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85 (01) 139-146
• 12 Zeng LH, Rana S, Hussain L. et al. Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Front Pharmacol 2022; 13: 874914
• 13 Parveen S, Das S. Homeopathic treatment in patients with polycystic ovarian syndrome: a case series. Homeopathy 2021; 110 (03) 186-193
• 14 Oberai P, Lamba C, Manchanda R, Rath P. et at. Evaluation of homoeopathic treatment in polycystic ovary syndrome: A single-blind, randomised, placebo-controlled pilot study. Ind J Res Homeopat 2018; 12 (01) 35
• 15 Lamba CD, Gupta VK, van Haselen R. et al. Evaluation of the modified Naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197